BlackRock Health Sciences Term Trust (NYSE:BMEZ – Get Free Report) saw a significant growth in short interest in February. As of February 28th, there was short interest totalling 261,100 shares, a growth of 49.7% from the February 13th total of 174,400 shares. Based on an average daily volume of 454,700 shares, the days-to-cover ratio is currently 0.6 days.
Institutional Investors Weigh In On BlackRock Health Sciences Term Trust
Several institutional investors have recently bought and sold shares of the company. Brown Brothers Harriman & Co. acquired a new stake in shares of BlackRock Health Sciences Term Trust in the third quarter worth approximately $32,000. Estabrook Capital Management purchased a new stake in shares of BlackRock Health Sciences Term Trust during the fourth quarter worth $35,000. Elequin Capital LP purchased a new stake in shares of BlackRock Health Sciences Term Trust during the fourth quarter worth $84,000. Yakira Capital Management Inc. acquired a new stake in shares of BlackRock Health Sciences Term Trust in the fourth quarter valued at about $153,000. Finally, K2 Principal Fund L.P. purchased a new position in shares of BlackRock Health Sciences Term Trust in the third quarter worth about $158,000.
BlackRock Health Sciences Term Trust Stock Up 1.2 %
Shares of BlackRock Health Sciences Term Trust stock traded up $0.18 on Friday, reaching $15.11. The company’s stock had a trading volume of 189,996 shares, compared to its average volume of 409,477. The stock has a 50-day moving average price of $15.80 and a 200-day moving average price of $15.65. BlackRock Health Sciences Term Trust has a 52-week low of $14.27 and a 52-week high of $16.75.
BlackRock Health Sciences Term Trust Dividend Announcement
BlackRock Health Sciences Term Trust Company Profile
BlackRock Health Sciences Trust II’s (BMEZ) (the ‘Trust’) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.
Recommended Stories
- Five stocks we like better than BlackRock Health Sciences Term Trust
- How to Invest in the Best Canadian Stocks
- Ignore Reports, Apple Won’t Install Starlink with iOS 18.3
- What is a support level?
- Casey’s Uptrend Remains Strong—New Highs on the Horizon
- What Investors Need to Know About Upcoming IPOs
- Taiwan Semiconductor’s Huge U.S. Move—Stock Impact Ahead
Receive News & Ratings for BlackRock Health Sciences Term Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Health Sciences Term Trust and related companies with MarketBeat.com's FREE daily email newsletter.